First Interim Efficacy and Safety Analysis of an International Phase III Randomized Trial in Newly Diagnosed Systemic Peripheral T-Cell Lymphoma Treated with Chemotherapy with or without Alemtuzumab and Consolidated by High Dose Therapy
Year: 2012
Type: conference-paper
Source: GRO
Authors: d’Amore, Francesco, Leppa, Sirpa, da Silva, Maria Comes, Relander, Thomas, Brown, Peter De Nully, Weidmann, Eckhart, Lauritzsen, Grete Fossum, Pezzutto, Antonio, van Hoof, Achiel, van Gelder, Michel, Doorduijn, Jeanette K., Wu, Ka Lung, Kluin-Nelemans, Hanneke C., Lugtenburg, P. J., Jankovska, Milada, Merup, Mats, Fagerli, Unn-Merete, Walewski, Jan, Hagberg, Hans, Mariz, Jose Mario, Hansen, Per Boye, Noesslinger, Thomas, Janssens, Ann, Brandefors, Lena, Demuynck, Hilde, Schaafsma, Martyn Ronald, Christiansen, Ilse, Salek, David, Jyrkkio, Sirkku, Prochazka, Vit, Zijlstra, Josee, Bohmer, L., Greil, Richard, Stevens, Wendy, Fijnheer, Rob, Kooy, Marinus van Marwijk, Grube, Matthias, Hopfinger, Georg, van den Neste, Eric, Jantunen, Esa, Truemper, Lorenz H., Wulf, Gerald, Altmann, Bettina, Ziepert, Marita, Loeffler, Markus, Toldbod, Helle
Language: English
Subfield: Pathology and Forensic Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W7207238366